首页> 外文期刊>International Journal of Clinical Oncology >Treatment-related ureteral cancer following stage II testicular seminoma
【24h】

Treatment-related ureteral cancer following stage II testicular seminoma

机译:II期睾丸精原细胞瘤后与治疗相关的输尿管癌

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We report two cases of left ureteral carcinoma that may have been related to prior radiotherapy and anticancer chemotherapy for stage II testicular seminoma. Both patients had undergone radiotherapy (60 Gy) and cisplatin-based chemotherapy, one 17 years before the present presentation and the other 24 years earlier. They underwent retroperitoneoscopy-assisted left nephroureterectomy under a diagnosis of left upper ureteral cancer, established by means of ureteroscopy and brush biopsy. The urologic and radiologic outcomes have been satisfactory after more than 2 years of follow-up. Recently, some investigators have reported that testicular cancer survivors are at significantly increased risk of solid tumors for at least 35 years after treatment. Young patients may have a high risk of cancer when they reach an advanced age.
机译:我们报告了两例左输尿管癌的病例,这些病例可能与II期睾丸精原细胞瘤的先前放疗和抗癌化疗有关。两名患者均接受了放疗(60 Gy)和基于顺铂的化疗,分别在本次就诊之前17年和其他24年之前。他们在通过输尿管镜检查和刷式活检确定为左上输尿管癌的情况下,进行了腹膜后辅助的左肾输尿管切除术。经过两年多的随访,泌尿科和放射学结果令人满意。最近,一些研究者报告说,睾丸癌幸存者在治疗后至少35年内患实体瘤的风险显着增加。年轻患者到高龄时可能会罹患癌症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号